Current and historical daily PE Ratio for CERO (
CERo Therapeutics Holdings Inc
) from 2024 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. CERo Therapeutics stock (CERO) PE ratio as of May 26 2024 is 0.
More Details
CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Chart
CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Historical Data
View and export this data going back to 2024. Start your Free Trial
Total 71
- 1
CERo Therapeutics PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-05-27 | At Loss | 2024-04-08 | At Loss |
2024-05-24 | At Loss | 2024-04-05 | At Loss |
2024-05-23 | At Loss | 2024-04-04 | At Loss |
2024-05-22 | At Loss | 2024-04-03 | At Loss |
2024-05-21 | At Loss | 2024-04-02 | At Loss |
2024-05-20 | At Loss | 2024-04-01 | At Loss |
2024-05-17 | At Loss | 2024-03-28 | At Loss |
2024-05-16 | At Loss | 2024-03-27 | At Loss |
2024-05-15 | At Loss | 2024-03-26 | At Loss |
2024-05-14 | At Loss | 2024-03-25 | At Loss |
2024-05-13 | At Loss | 2024-03-22 | At Loss |
2024-05-10 | At Loss | 2024-03-21 | At Loss |
2024-05-09 | At Loss | 2024-03-20 | At Loss |
2024-05-08 | At Loss | 2024-03-19 | At Loss |
2024-05-07 | At Loss | 2024-03-18 | At Loss |
2024-05-06 | At Loss | 2024-03-15 | At Loss |
2024-05-03 | At Loss | 2024-03-14 | At Loss |
2024-05-02 | At Loss | 2024-03-13 | At Loss |
2024-05-01 | At Loss | 2024-03-12 | At Loss |
2024-04-30 | At Loss | 2024-03-11 | At Loss |
2024-04-29 | At Loss | 2024-03-08 | At Loss |
2024-04-26 | At Loss | 2024-03-07 | At Loss |
2024-04-25 | At Loss | 2024-03-06 | At Loss |
2024-04-24 | At Loss | 2024-03-05 | At Loss |
2024-04-23 | At Loss | 2024-03-04 | At Loss |
2024-04-22 | At Loss | 2024-03-01 | At Loss |
2024-04-19 | At Loss | 2024-02-29 | At Loss |
2024-04-18 | At Loss | 2024-02-28 | At Loss |
2024-04-17 | At Loss | 2024-02-27 | At Loss |
2024-04-16 | At Loss | 2024-02-26 | At Loss |
2024-04-15 | At Loss | 2024-02-23 | At Loss |
2024-04-12 | At Loss | 2024-02-22 | At Loss |
2024-04-11 | At Loss | 2024-02-21 | At Loss |
2024-04-10 | At Loss | 2024-02-20 | At Loss |
2024-04-09 | At Loss | 2024-02-16 | At Loss |
CERo Therapeutics Holdings Inc (CERO) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
CERo Therapeutics Holdings Inc
NAICS : 541713
SIC : 2833
ISIN : US71902K1051
Description